• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Shattuck Labs Unveils 2025 Financials And Business Updates

    GLOBENEWSWIRE

    Shattuck Labs To Join Piper Sandler`s Immunology Symposium

    GLOBENEWSWIRE

    Shattuck Labs Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Shattuck Labs Joins December Investor Conferences

    GLOBENEWSWIRE

    Shattuck Labs Reveals Q3 2025 Financials & Business Updates

    GLOBENEWSWIRE

    Shattuck Labs To Join Wedbush Securities (KOL) & Company Panel

    GLOBENEWSWIRE

    Shattuck Labs Announces Closing of up to $103 M Private Placement

    GLOBENEWSWIRE

    Shattuck Labs` IND for SL-325 Approved for Bowel Disease

    GLOBENEWSWIRE

    Shattuck Labs reports Q2 2025 financials and business highlights

    GLOBENEWSWIRE

    Shattuck Labs to Join Leerink Partners Therapeutics Forum

    GLOBENEWSWIRE

    Shattuck Labs Reports Q1 2025 Financial Results & Highlights

    GLOBENEWSWIRE

    Shattuck Labs to Join 24th Annual Needham Virtual Healthcare Conf

    GLOBENEWSWIRE

    Shattuck Labs Reports Q4 and Full-Year 2024 Financial Results

    GLOBENEWSWIRE

    Shattuck Labs Presents SL-325 Preclinical Data At ECCO 2025

    GLOBENEWSWIRE

    Shattuck Labs to Present at 43rd J.P. Morgan Conference

    GLOBENEWSWIRE

    Shattuck Labs Provides Corporate Update & Key Milestones in 2025

    GLOBENEWSWIRE

    Shattuck Labs to Attend December Conferences

    GLOBENEWSWIRE

    Shattuck Labs Updates on SL-325, a DR3 Antagonist

    GLOBENEWSWIRE

    Shattuck Labs Reports Q2 2024 Results And Business Highlights

    GLOBENEWSWIRE

    Shattuck Labs To Participate In BTIG Virtual Biotechnology Conference

    GLOBENEWSWIRE

    Shattuck Reports Positive SL-172154 Data In HR-MDS And TP53m AML

    GLOBENEWSWIRE

    Shattuck Labs To Present SL-172154 + AZA Data In MDS/AML At EHA 2024

    GLOBENEWSWIRE

    Shattuck Labs Announces Positive Data from Ongoing Phase 1 Trial of SL-172154

    GLOBENEWSWIRE

    Shattuck Labs to Present Data from Phase 1 A/B Clinical Trial of SL-172154

    GLOBENEWSWIRE

    Shattuck to Present Complete Phase 1A Monotherapy Clinical Trial of SL-172154

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.